EUVIMEDEUVIMED entdecken
Crossref

A Two-Step Strategy Based on Fpg Recognition and RCA-CRISPR/Cas12a for Ultrasensitive Detection of Gene Mutation

Shiying Zhou iD, Tingting Xiang, Zengqin Cha, Jiayan Song, Yuanfang Xiang, Xiang Li, Chunlan Huang, Qibing Mei, Xinwu Huang, Chunxiang Zhang, Jianming Wu

Analytical Chemistry · 10.11.2026 · 98 (44) · 30873-30882

DOI: 10.1021/acs.analchem.6c04145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 14.10.2026. Verfasst von Shiying Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Southwest Medical University, Sichuan, Luzhou646000, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Mutation, Tumor Suppressor Protein p53, DNA-Formamidopyrimidine Glycosylase. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Sichuan Science and Technology Program, Sichuan Provincial Central Government-Guided Local Scientific Research Project, Luzhou Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate detection of gene mutations is crucial for acute myeloid leukaemia (AML) diagnosis and treatment. Although CRISPR/Cas systems enable sensitive mutation detection, their adaptability is constrained by dependence on restriction endonucleases. Herein, we propose a two-step strategy, termed Fpg-RCA-CRISPR/Cas12a for ultrasensitive detection of the p53 R175H, which integrates formamidopyrimidine DNA glycosylase (Fpg)-mediated recognition with rolling circle amplification (RCA)-coupled CRISPR/Cas12a technology. Validation confirmed that Fpg exhibits minimal activity when adenine (A) is opposite the damaged site. Based on this finding, we designed a padlock probe with a site-specific 8-oxoguanine (8-oxoG) modification. This modification enables selective recognition of G > A mutations. For the target TP53 c.524G > A (p53 R175H), the G > A substitution opposite the 8-oxoG site blocks Fpg cleavage, facilitating probe circularization and subsequent RCA. The resulting RCA products then activate the trans-cleavage activity of Cas12a, enabling cascade signal amplification and generating a strong fluorescence output. For wild-type p53, Fpg-mediated cleavage prevents circularization and amplification, yielding weak fluorescence. Taking advantage of the high specificity of the Fpg enzyme and the cascade amplification effect of the RCA−CRISPR/Cas12a system, this method achieves a limit of detection (LOD) of 0.29 fM and covers a linear range from 0.8 fM to 800 pM, along with high reproducibility, excellent selectivity, and negligible background interference. Notably, the assay can detect mutation frequencies as low as 0.1% in excess wild-type p53. Crucially, its clinical feasibility was confirmed by analyzing human serum samples, yielding results consistent with standard assays and thus demonstrating its practical reliability and translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsMutationTumor Suppressor Protein p53DNA-Formamidopyrimidine GlycosylaseNucleic Acid Amplification TechniquesHumansLimit of DetectionBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated Proteins

Stichwörter der Autor:innen

8-oxoGCRISPR/Cas12aFpg enzymeRCAp53 R175H

Substanzen

Tumor Suppressor Protein p53DNA-Formamidopyrimidine GlycosylaseCas12a proteinBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated Proteins

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Southwest Medical University, Sichuan, Luzhou646000, China.
  • Department of Chemistry, School of Basic Medical Sciences, Southwest Medical University, Sichuan, Luzhou646000, China.
  • School of Pharmacy, Southwest Medical University, Sichuan, Luzhou646000, China.
  • Stem Cell Immunity and Regeneration Key Laboratory of LuZhou, Affiliated Hospital of Southwest Medical University, Sichuan, Luzhou646000, China.
  • Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institut…

ORCID-Profile: Shiying Zhou

Förderung

  • Sichuan Science and Technology Program
  • Sichuan Provincial Central Government-Guided Local Scientific Research Project
  • Luzhou Science and Technology Program
  • The Science and Technology Strategic Cooperation Programs of Luzhou Municipal People's Government and Southwest Medical University
  • Natural Science Foundation of Sichuan Province
  • National Natural Science Foundation of China (NSFC)
  • The Science and Technology Strategic Cooperation Programs of Luzhou Municipal People’s Government and Southwest Medical University

Zitieren

APA

Zhou, S., Xiang, T., Cha, Z., Song, J., Xiang, Y., Li, X., Huang, C., Mei, Q., Huang, X., Zhang, C., & Wu, J. (2026). A Two-Step Strategy Based on Fpg Recognition and RCA-CRISPR/Cas12a for Ultrasensitive Detection of Gene Mutation. Analytical Chemistry, 98(44), 30873-30882. https://doi.org/10.1021/acs.analchem.6c04145

Vancouver

Zhou S, Xiang T, Cha Z, Song J, Xiang Y, Li X, et al. A Two-Step Strategy Based on Fpg Recognition and RCA-CRISPR/Cas12a for Ultrasensitive Detection of Gene Mutation. Analytical Chemistry. 2026;98(44):30873-30882. doi:10.1021/acs.analchem.6c04145

BibTeX
@article{Zhou2026,
  author = {Zhou, Shiying and Xiang, Tingting and Cha, Zengqin and Song, Jiayan and Xiang, Yuanfang and Li, Xiang and Huang, Chunlan and Mei, Qibing and Huang, Xinwu and Zhang, Chunxiang and Wu, Jianming},
  title = {A Two-Step Strategy Based on Fpg Recognition and RCA-CRISPR/Cas12a for Ultrasensitive Detection of Gene Mutation},
  journal = {Analytical Chemistry},
  year = {2026},
  volume = {98},
  number = {44},
  pages = {30873--30882},
  doi = {10.1021/acs.analchem.6c04145}
}
Kostenlos starten →